Dr. Boris Gliner, M.D

NPI: 1982648507
Total Payments
$7,878
2024 Payments
$971.35
Companies
42
Transactions
357
Medicare Patients
5,470
Medicare Billing
$506,625

Payment Breakdown by Category

Food & Beverage$7,847 (99.6%)
Education$31.24 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,847 355 99.6%
Education $31.24 2 0.4%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $700.76 26 $0 (2024)
Amgen Inc. $638.40 17 $0 (2019)
Novo Nordisk Inc $624.74 41 $0 (2024)
ABBVIE INC. $575.75 24 $0 (2024)
Lilly USA, LLC $536.14 15 $0 (2024)
Janssen Pharmaceuticals, Inc $529.10 30 $0 (2024)
AstraZeneca Pharmaceuticals LP $442.96 21 $0 (2024)
Phathom Pharmaceuticals, Inc. $374.97 3 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $361.04 10 $0 (2024)
GlaxoSmithKline, LLC. $265.41 5 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $971.35 31 Phathom Pharmaceuticals, Inc. ($374.97)
2023 $629.28 14 E.R. Squibb & Sons, L.L.C. ($165.13)
2022 $685.58 7 Lilly USA, LLC ($250.00)
2021 $260.19 4 AstraZeneca Pharmaceuticals LP ($121.70)
2020 $360.27 13 Esperion Therapeutics, Inc. ($115.96)
2019 $1,172 74 Janssen Pharmaceuticals, Inc ($181.17)
2018 $1,719 93 AbbVie, Inc. ($346.30)
2017 $2,080 121 Amgen Inc. ($350.28)

All Payment Transactions

357 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/30/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $17.40 General
Category: Diabetes
12/12/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $14.74 General
11/22/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $17.57 General
Category: Cardiovascular and Metabolism
11/21/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $15.40 General
Category: Cardiovascular and Metabolism
11/19/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $20.00 General
Category: Diabetes
11/14/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $37.30 General
Category: Endocrinology
11/07/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $22.76 General
Category: GASTROENTEROLOGY
10/16/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: GASTROENTEROLOGY
10/10/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $21.00 General
10/03/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $22.98 General
Category: Cardiovascular and Metabolism
09/20/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $18.29 General
Category: Cardio-renal
09/20/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $12.83 General
Category: Diabetes
08/29/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $18.34 General
Category: Diabetes
08/22/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.30 General
Category: DIABETES
08/12/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.52 General
Category: Diabetes
08/02/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $20.80 General
Category: Neuroscience
07/30/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $15.48 General
Category: Diabetes Care
07/20/2024 Azurity Pharmaceuticals, Inc. EDARBYCLOR (Drug) Food and Beverage In-kind items and services $15.51 General
Category: CARDIOVASCULAR
06/25/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $99.10 General
Category: Neuroscience
06/20/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.69 General
Category: Respiratory
06/13/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: GASTROENTEROLOGY
05/23/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $13.61 General
Category: Endocrinology
05/02/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $16.70 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
04/26/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.01 General
Category: Respiratory
04/18/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $19.83 General
Category: VACCINES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 1,149 1,750 $192,617 $97,307
2022 11 1,447 2,057 $218,548 $117,539
2021 9 1,363 2,196 $213,911 $154,358
2020 9 1,511 2,426 $207,866 $137,420
Total Patients
5,470
Total Services
8,429
Medicare Billing
$506,625
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 320 747 $77,525 $36,904 47.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 202 375 $55,205 $26,375 47.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 255 255 $35,902 $18,300 51.0%
99497 Advance care planning, first 30 minutes Office 2023 76 76 $7,510 $4,427 58.9%
G0008 Administration of influenza virus vaccine Office 2023 128 128 $4,150 $3,758 90.6%
90756 Influenza vaccine, quadrivalent derived from cell cultures Office 2023 66 66 $2,310 $2,094 90.6%
99496 Transitional care management services for problem of high complexity Office 2023 13 13 $3,800 $2,081 54.8%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 13 13 $3,580 $1,577 44.0%
90688 Influenza vaccine, quadrivalent, 0.5 ml dosage Office 2023 64 64 $1,600 $1,309 81.8%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 12 13 $1,035 $482.52 46.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 331 721 $70,995 $35,812 50.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 262 476 $65,410 $31,585 48.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 323 323 $46,068 $26,438 57.4%
99497 Advance care planning, first 30 minutes Office 2022 141 141 $14,100 $9,267 65.7%
G0008 Administration of influenza virus vaccine Office 2022 157 157 $3,880 $3,696 95.3%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 15 15 $2,480 $2,320 93.6%
90756 Influenza vaccine, quadrivalent derived from cell cultures Office 2022 74 74 $2,590 $2,216 85.6%
99495 Transitional care management services for problem of moderate complexity Office 2022 15 17 $4,305 $1,646 38.2%
90688 Influenza vaccine, quadrivalent, 0.5 ml dosage Office 2022 82 82 $2,050 $1,646 80.3%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2022 35 38 $3,070 $1,510 49.2%
99496 Transitional care management services for problem of high complexity Office 2022 12 13 $3,600 $1,403 39.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 391 1,085 $103,075 $66,391 64.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 342 342 $48,566 $44,559 91.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 199 328 $42,940 $29,794 69.4%
G0008 Administration of influenza virus vaccine Office 2021 185 185 $4,650 $2,995 64.4%

About Dr. Boris Gliner, M.D

Dr. Boris Gliner, M.D is a Internal Medicine healthcare provider based in Parma, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982648507.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Boris Gliner, M.D has received a total of $7,878 in payments from pharmaceutical and medical device companies, with $971.35 received in 2024. These payments were reported across 357 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,847).

As a Medicare-enrolled provider, Gliner has provided services to 5,470 Medicare beneficiaries, totaling 8,429 services with total Medicare billing of $506,625. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Specialist
  • Location Parma, OH
  • Active Since 06/15/2006
  • Last Updated 09/24/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1982648507

Products in Payments

  • ELIQUIS (Drug) $650.26
  • JARDIANCE (Drug) $520.52
  • VOQUEZNA (Drug) $374.97
  • NURTEC ODT (Drug) $338.34
  • XARELTO (Drug) $327.72
  • Creon (Drug) $262.33
  • Prolia (Biological) $249.54
  • ENTRESTO (Drug) $228.06
  • Victoza (Drug) $212.40
  • Repatha (Biological) $209.74
  • Ozempic (Drug) $185.28
  • AJOVY (Drug) $169.48
  • Livalo (Drug) $153.08
  • FARXIGA (Drug) $152.86
  • CHANTIX (Drug) $152.71
  • Aimovig (Biological) $148.83
  • BREZTRI (Drug) $135.02
  • SHINGRIX (Biological) $133.74
  • MOUNJARO (Drug) $125.00
  • GVOKE HYPOPEN (Drug) $124.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Parma